Biofield Corp. Strengthens Balance Sheet through Equity Investment and Debt Conversion

PHILADELPHIA & HONG KONG--(BUSINESS WIRE)--Biofield Corp. (OTCBB:BZEC), a medical technology company which develops and acquires noninvasive diagnostic medical devices to assist in detecting and preventing cancer and other illnesses for use in the world’s largest population centers, announced today that it received an equity investment of $110,000 as well as a conversion $422,000 of debt and accrued interest.